The present invention relates to topical pharmaceutical composition comprising i) miconazole or salts thereof; and ii) luliconzole or salts thereof. The composition in the treatment of fungal infection. The topical pharmaceutical composition according to present invention provides synergism which broadens the spectr...
The present disclosure relates to tamper-proof dosage form comprising oncological pharmaceutically active agent or other active ingredient which is susceptible to topical or nasal contact. The tamper-proof dosage form according to present invention resist crushing, cutting or chewing and prevents topical and inhalat...
The present disclosure relates to effervescent compositions comprising Saxagliptin or salt thereof and manufacturing process for the same. The effervescent compositions comprises acidic agent, basic agent optionally with one or more pharmaceutically acceptable excipient. The effervescent compositions provide quick d...
The present invention relates to novel pharmaceutical composition comprising DPP-4 inhibitor, Alpha-lipoic acid and Vitamin B12. The synergism of DPP-4 inhibitor, Alpha-lipoic acid and Vitamin B12 helps in the treatment of diabetes and diabetes associated complications.
The present disclosure relates to novel hydroxyl or halogen substituted derivatives of C11-C22 alkanoic acid ester of Paliperidone compound of formula and process for preparing the same. The said compounds used in pharmaceutical composition for the treatment of schizophrenia and schizoaffective disorder.
...
The present disclosure relates to effervescent compositions comprising Rifaximin or salt thereof and manufacturing process for the same. The effervescent composition comprises at least one acidic agent and at least one basic agent along with one or more pharmaceutically acceptable excipient. The effervescent composi...
The present invention relates to Suprabioavailable oral composition of Pirfenidone or salt thereof when compared with reference product of Pirfenidone capsule [267mg] and tablet [267mg and 801mg] for the treatment of idiopathic pulmonary fibrosis (IPF). The Suprabioavailable oral composition of Pirfenidone or salt t...
ABSTRACT
The present invention relates to antifungal cuticle oil composition comprising Efinaconazole or Tavaborole or Terbinafine or salt thereof in the treatment of onychomycosis. The topical antifungal cuticle oil according to present invention provides better penetration and application at affected site results...
NOVEL PHARMACEUTICAL COMPOSITION COMPRISING DICYCLOMINE OR SALT THEREOF AND MEFENAMIC ACID
The present invention relates to novel pharmaceutical composition comprising Dicyclomine or salt thereof and Mefenamic acid. The novel composition according to present invention provides immediate release of Dicyclomine or sa...
The present disclosure relates to the ready to use intravenous infusion of Brivaracetam or salt thereof. The ready to use intravenous infusion of Brivaracetam or salt thereof provides longer stability, which can be administered for longer period of time, with direct use without prior dilution, which saves time for d...
The present invention relates to a low dose topical composition comprising triamcinolone acetonide or salt thereof in an amount of less than 250 mcg/gm, its process of preparation and its use for the treating/preventing of various types of skin diseases, preferably atopic dermatitis in infants, children, adults and ...
The present invention relates to a novel pharmaceutical composition comprising combination of Olopatadine or salt thereof and Nepafenac or salt thereof, process for preparation thereof and use thereof for the treatment of ophthalmic disorders.
The present invention relates to a novel pharmaceutical or nutraceutical composition comprising multivitamins, minerals, coenzyme, amino acids and omega-3 fatty acids, and process of preparation and its prophylactic or supportive use as an adjuvant to anticonvulsant medicines used for treating/preventing of various ...
The present disclosure relates to effervescent compositions comprising Chlorpromazine or salt thereof and manufacturing process for the same. The effervescent composition comprises at least one acidic agent and at least one basic agent along with one or more pharmaceutically acceptable excipient. The effervescent co...
The present invention relates to synergistic pharmaceutical composition comprising a guanosine analogue selected from Acyclovir and Penciclovir; Docosanol and Hydrocortisone. The pharmaceutical composition in the form of topical according to present invention is more potent, efficacious and provides better patient c...
The present invention relates to novel pharmaceutical composition comprising Mefenamic acid and other analgesic or salt thereof. The novel composition according to present invention provides modified release of mefenamic acid and immediate release of ther analgesic in the treatment of dysmenorrhea.
...
The present disclosure relates to novel pharmaceutical composition comprising Alcaftadine and Nepafenac along with antibacterial and/or antiviral and/or antifungal drug in the treatment of ophthalmic disorders which counteracts the allergies, inflammation and infection associated with eye.
The present disclosure relates to the intranasal drug delivery system or composition of Brivaracetam or salt thereof. The nasal drug delivery Brivaracetam or salt thereof preferably in the form of Nasal sprays provide more bioavailability better onset of action, lesser adverse effects; better ease of self-administra...
The present invention relates to improved topical composition of Colchicine or a pharmaceutically acceptable salt thereof as an active agent and, process of preparing such improved topical composition. The invention also relates to the use of said improved topical composition for prophylaxis and the treatment of acu...
The present disclosure relates to novel hydroxyl or halogen or hydrogen substituted derivatives of Palmitic acid or Palmitoyl halide amide of Linagliptin compound of formula I and process for preparing the same. The said compounds used in pharmaceutical composition for the treatment of type 2 diabetes mellitus, wher...
The present invention relates to a sublingual composition comprising nintedanib or salt thereof as an active agent, process of preparation thereof and method of using the same for the treatment of idiopathic pulmonary fibrosis, chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, systemi...
The present invention relates to a stable liquid pharmaceutical composition comprising Obeticholic acid or its salts and one or more pharmaceutically acceptable excipients and its process of preparation and its use for the treatment of adult patients with primary biliary cholangitis (PBC).
A present invention relates to a vaginal pharmaceutical composition for treating vaginal infections comprising Miconazole or its salts and Luliconazole or its salts, its process of preparation and its use for the treatment/prevention of vaginal infections.
The present invention relates to a pharmaceutical composition comprising oyster peptide and PDE5 Inhibitor or salts thereof, its process of preparation and method of use of said pharmaceutical composition. More particularly the present invention relates to a pharmaceutical composition for oral administration compris...
The present invention relates to topical pharmaceutical composition comprising i) luliconzole or salts thereof; and ii) ketoconazole or salts thereof and iii) one or more pharmaceutically acceptable excipient. The composition in the treatment of fungal infection(s). The topical pharmaceutical composition according t...
The present invention relates to Supra bioavailable oral composition of Chlorzoxazone or salt thereof when compared with approved tablet strength of Chlorzoxazone [375mg, 500mg, 750mg] for the treatment of muscle spasm. The Supra bioavailable oral composition of Chlorzoxazone or salt thereof provides at least 5% dos...
NUTRACEUTICAL COMPOSITION COMPRISING FULVIC ACID, FISETIN AND ONE OR MORE NUTRACEUTICALS, VITAMINS AND MINERALS
The present invention relates to a novel nutraceutical composition comprising Fulvic acid, Fisetin and one or more Nutraceuticals, Vitamins and Minerals, and process of preparation. This composition is us...